Spero Therapeutics, Inc. (SPRO) News Headlines

▮ More

Date

Headline

7/16/2019 8:14:45 AM Spero Therapeutics Receives $5.9 Mln Award From DoD

6/13/2019 8:09:57 AM Spero Announces $10 Mln Registered Direct Offering Of Common Stock

3/29/2019 8:12:04 AM Spero Therapeutics Gets FDA Fast Track Designation For SPR994 For CUTI And Acute Pyelonephritis

2/4/2019 7:07:49 AM Spero Therapeutics Announces FDA Acceptance Of IND Application For SPR994

11/5/2018 8:05:28 AM Spero Announces Positive Results From SPR720 IND-Enabling Studies And Plans To Initiate A Phase 1 Trial

10/16/2018 9:40:07 PM CRMD On Watch, SPRO On Track To Initiate Phase 3 Trial, BMRA's Sales Drop

10/11/2018 8:03:58 AM Spero Therapeutics Secures QIDP Designation From FDA For Development Of SPR206

9/2/2018 11:13:15 AM 10 Pharma Stocks To Watch This Month

8/10/2018 4:38:45 AM SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch

7/17/2018 1:53:10 AM EOLS Slumps On Stock Offering, BLCM CFO To Exit, NVRO Trims Revenue Outlook

7/16/2018 7:03:58 AM Spero Therapeutics Secures Funding Of $15.7 Mln, With Potential For Up To Addl $28.5 Mln Over 5 Years, From BARDA

7/10/2018 2:39:24 AM ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN

7/9/2018 4:12:32 PM Spero Therapeutics Announces Proposed Offering Of Common Stock

7/9/2018 7:31:40 AM Spero Therapeutics Announces Positive Interim Phase 1 SAD/MAD Results For SPR994

6/19/2018 8:39:40 PM CLBS Firing On All Cylinders, SLDB Gets Ignited, SRPT Walks The Talk, SRRK Rocks

5/23/2018 8:07:03 AM Spero Therapeutics Announces Positive Top-Line Data For Two Product Candidates From Its Potentiator Platform

5/11/2018 1:11:45 AM BLFS Q1 Revenue Up 61%, VRAY Garners Attention, AKCA Gets FDA Panel Nod

4/12/2018 8:01:50 AM Spero Therapeutics Appoints Ian Critchley As Head Of Clinical Microbiology

4/2/2018 4:23:13 PM Spero Therapeutics Q4 Loss/share $1.59 Vs. Loss $25.68 Year Ago

1/4/2018 7:34:08 AM Spero Therapeutics Names David Melnick Chief Medical Officer